drugset / Trial / NCT00002796

Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer

NCT00002796

Phase 1/2 Terminated 46 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Interferon-gamma may interfere with the growth of tumor cells and slow the growth of the tumor. Combining more than one drug with interferon-gamma may kill more tumor cells. This phase I/II trial is studying the side effects and best dose of giving fluorouracil together with phenylbutyrate, indomethacin, and interferon-gamma and to see how well it works in treating patients with stage IV colorectal cancer

Timeline

Start
1997-05
Primary completion
2004-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject fluorouracil Small molecule Intravenous
Background Indomethacin Small molecule Oral
Background Interferon gamma-1b Protein / enzyme biologic Subcutaneous
Background Sodium Phenylbutyrate Small molecule Intravenous